Bonita Biotech (HK) Ltd - 09 Dec 2025 SCHEDULE 13G/A Report for Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)

Filing manager: Bonita Biotech (HK) Ltd
Reporting owner: Biosion, Inc.
Security: Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value
Beneficially owned shares: 11,281,950 shares
Class ownership: 9.4%
Large-stake signal: Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Ownership
9.4%
Beneficial ownership of this reported class.
Shares
11,281,950 shares
Shares beneficially owned as disclosed.
Event date
09 Dec 2025
Date tied to the ownership event or amendment.
Accepted by SEC
09 Jan 2026
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Symbol: ACRS
Shares outstanding: 120,020,745 shares
Form type: SCHEDULE 13G/A
Accepted by SEC: 09 Jan 2026, 08:59:56 UTC
Event date: 09 Dec 2025
SEC filing: View on sec.gov

Key filing fact

Bonita Biotech (HK) Ltd disclosed 9.4% ownership in Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS) on 09 Dec 2025.

Key facts

Bonita Biotech (HK) Ltd filed SCHEDULE 13G/A for Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS).
Disclosed ownership: 9.4%.
Date of event: 09 Dec 2025.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Sole voting power	Shared voting power	Signature	Title	CIK
Biosion, Inc.	9.4%	11,281,950	11,281,950	0	/s/ MINGJIU CHEN	MINGJIU CHEN / CEO
Bonita Biotech (HK) Ltd	9.4%	11,281,950	11,281,950	0	/s/ MINGJIU CHEN	MINGJIU CHEN / Director

CIK / CUSIP context first

Broader feeds